China Bio-Immunity Corporation Completes Share Exchange and Reve... ( 13.2 Million Common Shares...)

China Bio-Immunity Corporation Completes Share Exchange and Reverse Merger

Date:8/6/2008

13.2 Million Common Shares Issued and Listed on OTCBB

DALIAN, China, Aug. 6 /Xinhua-PRNewswire-FirstCall/ -- China Bio-Immunity Corporation (OTC Bullets and Board: CHHB) (''China Bio-Immunity" or "the Company''), today announced that it has entered into a share exchange agreement with Lawford Asia Limited (''Lawford''). According to the share exchange transaction agreement, China Bio-Immunity acquired all of the issued and outstanding stock of Lawford in exchange for the issuance of 13,246,697 shares of its common stock.

Lawford is the holding company of Dalian Jingang-Andi Bio-Products Co. Ltd. (''JGAD''). Under the share exchange agreement, China Bio-Immunity will carry out the business of JGAD as its sole line of business. JGAD is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily within China.

The Company's revenue generating product portfolio is primarily comprised of Rabies Vaccine for Human Use with Vero Cell, a unique biological product that is used to effectively control and combat rabies disease, and Mumps Vaccine, which is produced from the live, attenuated S79 strain of the mumps virus. In addition to its current products, the Company's product pipeline includes five next-generation vaccine-based prophylactics and therapeutics in various stages of development for both the prevention and treatment of various viruses and infectious diseases. The Company believes that the potential launch of its pipeline products will bring significant market opportunities in the next three to five years.

In conjunction with the share exchange agreement, the Company today filed a Current Report on Form 8-K with the Securities and Exchange Commission, which discloses detailed information about the Company and its subsidiaries, including financial statements for the fiscal years ended December 31, 2006 and 2007, and the three months per
'/>"/>

SOURCE China Bio-Immunity Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
2. UNC School of Social Work helps China tackle growing pains
3. Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics
4. China Shenghuo Pharmaceutical Retains Grayling Global As Investor Relations Counsel
5. China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008
6. China Medicine Corporation Obtains Australian Patent for rADTZ
7. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
8. AmeriCares Purchases 2nd BLU-MED Deployable Field Hospital for China Earthquake Relief
9. Closing coal-burning power plant in China and improved cognitive development in children
10. China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
11. AmeriCares Meets Long-Term Health Needs of Disaster Victims in China and Myanmar

Post Your Comments:

(Date:12/3/2009)... The Lifestyle Advisors at V... Gifts to ease the stress of finding that perfect ...the DIY treatments in health, fitness and wellness...e on time and within budget. , ...son mySpaShop (mSS), has gathered an assortment ...

(Date:12/3/2009)... Mailing a five pound gift a...llars for postage. Now the worldwide postage is f... gift book purchased online at www.oakanahouse.co... 2009 -- Mailing a five pound gift to Paris, Perth...ostage. But that,s 40 dollars they can keep in th...

(Date:12/2/2009)... , GRAND RAPIDS, Mich., Dec. 3 /PRNewswire/...s have determined precisely how the plant hormone ...o help plants respond to environmental stresses su... in the journal Nature , could help engineer crop...ld and combat global food shortages. The findings...

(Date:12/2/2009)... , NEW YORK, Dec. 2 Re...h report is available in its catalogue: ,, Poi...nker.com/p0166822/Point-of-Care-Diagnostics.html ...he point of care (POC) diagnostics industry ,, .... POC diagnostics industry ,, Covers federal r...

(Date:12/2/2009)... , BOSTON, Dec. 2 ...site traffic rises 8%. According to Coremetrics, ...ose 13.7 percent on Cyber Monday compared to Cyber...oston,s Bella Sante Day Spas who reported today ...onday Internet sales rose 59%" - said Tiffany Amor...

[0] Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments [0] Greg Lawson Americana Photography Gift Books Now Offered with Free Shipping Worldwide [1] VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops [0] Reportlinker Adds Point of Care Diagnostics [0] The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%.

.... 4 HEI, Inc. (Nasdaq: HEII,-- http://www.heii.c...e of,substantially all of the assets of its RFID d...owned subsidiary of Dutch based Smartrac N.V. The,...er lists, and the assumption of substantially all ...

...ng to be Held September 20, 2007, READING, Pa., S...today urged shareholders to vote in favor of its,p...YSE: TFX ) and for the,reelection of the current ... B. Fleck, President,and Chief Executive Officer, ...

...eptember 4, 2007) The results of a clinical trial...trics, indicates that, when used as part of routin...ive in slowing down lung disease in children with ... Health Centre, the multi-centre study monitored 1...

...t. 4 WellPoint, Inc. (NYSE:,WLP) announced today ...the,following conferences: * Bear Stearns 20th An... beginning at 2:00 p.m. Eastern Daylight Time (E...* Merrill Lynch Global Pharmaceutical, Biotech & M...

...gotiation with Carticept for Commercialization and...l Medical Market, LIVINGSTON, N.J., Sept. 4 Mile...today announced that it has,successfully concluded...he treatment of arthritic joints. Work under,the C...

...- A combination of two drugs shows promise in trea... that originates in the eye and spreads to other o...sity Comprehensive Cancer Center researchers. , ... cancer cell death. , Metastatic uveal melanoma, ...

Other Medicine News:Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2 Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 2 Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 3 Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 4 Health News:Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors 5 Health News:WellPoint Announces Appearances at Upcoming Conferences 2 Health News:Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical 2 Health News:Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical 3 Health News:Promising drug combination may help those with ocular melanoma that has spread 2

HEI, Inc. Closes on Sale of RFID Division Assets Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows WellPoint Announces Appearances at Upcoming Conferences Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical Promising drug combination may help those with ocular melanoma that has spread

(Date:12/2/2009)..., LITTLE FALLS, N.J., Dec. 2 /PRNewswire-FirstCal...ease the results for its first quarter ended Octob... and hold a conference call to discuss the results...e Charles M. Diker, Chairman; Andrew A. Krakauer, ...resident; Craig A. Sheldon, Senior Vice President,...

(Date:12/2/2009)... , LEXINGTON, Mass. and HEIDELBERG, Germany, De...cognized as one of the winners of the "Top 10 Inno...company,s automated sequence capture technology fo...ts exceptional combinations of invention, vision a...l of expert judges to evaluate a broad range of li...

(Date:12/2/2009)..., LAKE FOREST, Ill., Dec. 2 /PRNewswire-FirstCa...vider of clinical information and medication deliv...ired Salt Lake City-based TheraDoc, a clinical inf...ce systems. TheraDoc,s two leading products, Infec...t(TM), join Hospira,s expanding portfolio of medic...

[0] Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 [0] The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009'[0] Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings

...Md.--(BUSINESS WIRE)--May 30, 2007 - Rexahn,Pharma... company,dedicated to the discovery, development, ... cancer, central nervous system disorders,sexual ...nnounced,that Dr. John Marshall, Principal Investi...ead cancer compound RX-0201 (Archexin),will prese...

...and CARLSBAD, CA, May 31, 2007 /PRNewswire-FirstCa...euticals, Inc. today,announced that preliminary da...e presented at the American Society of Clinical,On...nclude data,from a Phase II clinical study of OGX-... from a Phase I/II clinical study of,OGX-011 in no...

Other Medicine Technology:OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2 OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3 OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4

Data from Rexahn Pharmaceuticals' Phase I Trial of RX-0201,(Archexin) to Be Presented at the 43rd American Society of Clinical,Oncology Annual Meeting in Chicago OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO

Toxo IgM EIA

Toxo IgG EIA

Pylori Detect IgG EIA

MonoFluo Legionella pneumophilia IFA Test

Medicine Products:

Toxo IgM EIA Toxo IgG EIA Pylori Detect IgG EIA MonoFluo Legionella pneumophilia IFA Test

China Bio-Immunity Corporation Completes Share Exchange and Reve...( 13.2 Million Common Shares...),Health